🗂️

Archived grant — no longer open

This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.

grant

Harnessing engineered T regulatory cells to promote beta cell health in T1D

Organization BENAROYA RESEARCH INST AT VIRGINIA MASONLocation SEATTLE, UNITED STATESPosted 8 Apr 2022Deadline 31 Jan 2026 ⚠️
NIHUS FederalResearch GrantFY20250-11 years old21+ years oldAddressAdultAdult HumanAffectAntigen PresentationAntigensAutoimmune DiseasesAutoimmune ResponsesAutoimmune StatusAutoimmunityB9 endocrine pancreasBeta CellBrittle Diabetes MellitusCD4 CellsCD4 Positive T LymphocytesCD4 T cellsCD4 helper T cellCD4 lymphocyteCD4+ T-LymphocyteCD4-Positive LymphocytesCD8CD8BCD8B1CD8B1 geneCell BodyCell Communication and SignalingCell FunctionCell PhysiologyCell ProcessCell ProtectionCell SignalingCell SurvivalCell ViabilityCellsCellular ExpansionCellular FunctionCellular GrowthCellular PhysiologyCellular ProcessCellular StressCellular Stress ResponseCellular injuryChildChild YouthChildren (0-21)ClinicalCytoprotectionDiseaseDisorderDysfunctionER stressElementsEndocrine PancreasEngineered GeneEngineeringEnvironmentFOXP3FOXP3 geneForkhead Box P3Functional disorderGenesGoalsHealthHomeHomingHumanHumulin RHyperglycemiaIDDMImmune TargetingImmunosuppressionImmunosuppression EffectImmunosuppressive EffectInflammationInflammatoryInsulinInsulin CellInsulin Secreting CellInsulin-Dependent Diabetes MellitusInterventionIntracellular Communication and SignalingInvestigatorsIslands of LangerhansIslets of LangerhansJM2Juvenile-Onset Diabetes MellitusKetosis-Prone Diabetes MellitusKnowledgeLYT3MHC ReceptorMajor Histocompatibility Complex ReceptorMeasuresMediatingModern ManNesidioblastsNovolin ROrganPancreasPancreaticPancreatic IsletsPars endocrina pancreatisPhysiopathologyPreventionRecoveryRegular InsulinRegulatory T-LymphocyteResearch PersonnelResearchersRiskSCURFINSignal TransductionSignal Transduction SystemsSignalingSiteSpecificityStressSubcellular ProcessSudden-Onset Diabetes MellitusSuppressor CellsSuppressor-Effector T-CellsSuppressor-Effector T-LymphocytesT Suppressor CellT-Cell ActivationT-Cell Antigen ReceptorsT-Cell ReceptorT-CellsT-LymphocyteT1 DMT1 diabetesT1DT1DMT4 CellsT4 LymphocytesTeff cellTestingTherapeuticTimeTregType 1 Diabetes MellitusType 1 diabetesType I Diabetes MellitusWorkactivate T cellsadulthoodantigen based testantigen testautoimmune attackautoimmune conditionautoimmune destructionautoimmune disorderautoimmune pathogenesisautoimmunity diseasebiological adaptation to stressbiological signal transductioncell damagecell growthcell injurycell stresscellular damageconstitutive expressionconstitutive gene expressioncytoprotectivedamage to cellsdeamidationdesigndesigningdraining lymph nodeeffector T cellendoplasmic reticulum stressengineered T cellsengineered immune systemgenetically engineered T-cellshomeshyperglycemicimmune engineeringimmune suppressionimmune suppressive activityimmune suppressive functionimmunoengineeringimmunogenimmunosuppressive activityimmunosuppressive functionimmunosuppressive responseinjury to cellsinjury to tissueinsulin dependent diabetesinsulin dependent type 1isletislet autoantibodyislet cell antibodyjuvenile diabetesjuvenile diabetes mellitusketosis prone diabeteskidsknowledge integrationlentiviral-transducedlentivirally transducedlentivirus transducedmouse modelmurine modelnative protein drugneo-antigenneo-epitopesneoantigensneoepitopesnovelpathophysiologyperipheral bloodpharmaceutical proteinprotein drug agentprotein-based drugreaction; crisisregional lymph noderegulatory T-cellsrepairrepairedsite targeted deliverystress responsestress; reactionsuppressor T lymphocytetargeted deliverytargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttherapeutic proteinthymus derived lymphocytetissue injurytissue repairtransgenic T- cellstype I diabetestype one diabetesyoungsterβ-cellβ-cellsβCell

Applications closed.

Description preview

Summary
Type 1 diabetes (T1D) is characterized by the destruction of β-cells, driven through autoimmune attack directed

at the pancreatic islet. In concert with β-cell destruction, β-cell stress and injury contribute to disease by initiating

enzymatic activities that compromise β-cell function and generate neoantigens. The investigators of this…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Harnessing engineered T regulatory cells to promote beta cell health in T1D — BENAROYA RESEARCH INST AT VIRGINIA MASON | | Dev Procure